Skip to content
USPeptideRxLearnApply for an account

Compliance · State rules

Office-use compounding in New Mexico

Silent on the human side; two express veterinary grants sit beside it
USPeptideRx EditorialLast reviewed:

New Mexico has written no human office-use provision anywhere in its pharmacy rules or its Pharmacy Act. What it has written, twice, is a veterinary one — a non-sterile grant of long standing and a sterile grant that is only months old and materially stricter. That contrast is the finding: the state knew how to write this permission and wrote it for animals. But the flat sentence "New Mexico bans office use" is refutable in a line, because a live wholesale exemption covers minimal quantities supplied to a practitioner for office use, and New Mexico separately provides a non-patient-specific drug-order instrument. Neither authorises compounding for office use; both make the absolute claim wrong.

The governing rule

New Mexico’s office-use position is set by NMAC 16.19.30.9(A)(4)(d) and 16.19.36.16(D) (veterinary); 16.19.8.7(DDD)(5). The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

NMAC 16.19.36.16(D)(5) — the veterinary legend, and the only office-use legend New Mexico has
For administration only. Not for dispensing or resale.
NMAC 16.19.8.7(DDD)(5) — the wholesale exemption that refutes the flat sentence
minimal quantities of drug by a licensed retail pharmacy to a licensed practitioner for office use

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

Silence on the human side, established by search rather than assumedHigh confidence
No human office-use provision appears anywhere in the relevant title of the administrative code — thirty-seven parts, or the Pharmacy Act. The two express office-use rules that do exist both say the drugs are to be used by veterinarians in their office.
The newer veterinary rule is materially stricter, and it is months oldHigh confidence
The sterile veterinary grant took effect on 18 November 2025 and nothing preceded it. It is tighter than its non-sterile counterpart in three ways: an emergency-condition gate, a gate requiring that the product not be available from an outsourcing facility, and a federal manufacturer-registration requirement for controlled substances.A state writing a NEW office-use rule in late 2025 and confining it to veterinarians, with tighter conditions than the older one, is better evidence of intent than an old silence would be.
Why the flat "bans office use" sentence is wrongHigh confidence
Two things sit against that sentence. A live wholesale-licensure exemption covers the sale of minimal quantities by a licensed retail pharmacy to a licensed practitioner for office use — qualitative, undefined, and a genuine exemption. And New Mexico supplies a non-patient-specific "drug order" instrument. Neither authorises compounding for office use, which is the question this page answers. Both refute the absolute claim.
QuantityHigh confidence
Both veterinary limbs use a reasonable-quantities standard, and the wholesale exemption uses minimal quantities. None of the three is defined by number.
The veterinary limb routes to federal lawHigh confidence
The newer sterile veterinary rule conditions the arrangement on ordering and distribution occurring in compliance with applicable state and federal law, which hands the federal question back rather than answering it. That is the conduit pattern, on the one limb New Mexico did write.

New Mexico at a glance

New Mexico office-use compounding summary, reviewed 2026-08-30
Human office useNo human provision; two express veterinary grants
Sterile preparationsYes on the veterinary limb — the newer sterile rule is stricter
Quantity capQualitative only — reasonable and minimal quantities, undefined
Mandatory label legendVeterinary only — "For administration only. Not for dispensing or resale."
Board reportingNone for office use
Last changeSterile veterinary rule new, effective November 2025
Governing ruleNMAC 16.19.30.9(A)(4)(d) and 16.19.36.16(D) (veterinary); 16.19.8.7(DDD)(5)

Receiving 503B office stock in New Mexico

New Mexico is the state that refutes the usual lesson in the positive direction. The expectation was that a 503B would be captured as a manufacturer, because the Board licenses manufacturers and wholesalers directly. It is not: New Mexico created a dedicated outsourcing-facility class in 2019.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What New Mexico asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inMedium confidence
An outsourcing facility licence from the Board of Pharmacy — a dedicated class created by statute in 2019 — at $2,000 biennially plus a $150 initial inspection, per location.Two things to check rather than assume. The trigger reaches compounded STERILE drugs, so a facility compounding only non-sterile product is not obviously captured by it, though the wholesale and manufacturer hooks would likely reach it anyway. And the biennial fee sits against a statutory cap expressed as a lower annual figure; the two are arithmetically reconcilable but we have not confirmed the reconciliation.
Does your practice need a permit?Medium confidence
This page does not establish a separate New Mexico facility credential for a receiving practice. The question New Mexico answers clearly is the supply side, and the answer there is that no human compounding permission exists.
Administer vs dispenseHigh confidence
The only place New Mexico draws this line for office stock is the veterinary legend, which says the product is for administration only and not for dispensing or resale. There is no human counterpart to compare it against.
Scheduled (controlled) stockHigh confidence
The Board registers controlled substances, and shipping them into the state requires both the federal registration and the Board’s. On the newer veterinary limb, controlled substances additionally require federal manufacturer registration.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever New Mexico law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how New Mexico compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

  • The rule quoted here as 16.19.36.16 is not yet in the state’s published compilation of Part 36. That compilation runs to section 15 and stops, nine months after the amendment took effect, so the text on this page is cited to the New Mexico Register issue that promulgated it rather than to the compilation. Anyone checking Part 36 on the compilation alone will not find this section and may conclude it does not exist.
  • Whether a facility compounding only non-sterile product is captured by New Mexico’s outsourcing-facility trigger is unresolved. The trigger names compounded sterile drugs, and the seam has not been tested — the wholesale and manufacturer hooks would probably reach such a facility, but that is a reading rather than an answer.
  • The biennial outsourcing-facility fee sits against a statutory cap expressed as a lower annual figure. The two are arithmetically reconcilable and we have not confirmed the reconciliation, so treat the published figure as needing a call before it is budgeted.
  • We searched no case law, attorney-general opinions, board newsletters or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.

  1. [1]NMAC Title 16 Chapter 19 Part 30 — pharmacy practice, including the non-sterile veterinary grant
  2. [2]NMAC 16.19.8.7 — wholesale drug distribution definitions; the office-use exemption at Subsection DDD, Paragraph (5)
  3. [3]New Mexico Register, Vol. XXXVI Issue 22 (18 November 2025) — the amendment adding 16.19.36.16
  4. [4]21 U.S.C. § 353a — Pharmacy compounding (Cornell LII)